This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
What the researchers found
GLP-1 RAs increase gallstone and gallbladder inflammation risk through suppression of cholecystokinin, altered bile acid composition, and rapid weight loss-related cholesterol supersaturation.
Why it matters
Gallbladder problems are one of the most clinically significant side effects of GLP-1 drugs. Understanding the mechanisms could help prevent them.
The numbers in context
Mechanisms: CCK suppression, bile acid alterations, weight loss-related cholesterol supersaturation; risk increases with dose and duration.
How the study worked
Narrative review of molecular mechanisms and clinical evidence for GLP-1 RA-associated biliary disease.
Who was studied
Patients on GLP-1 RAs for T2DM or obesity
What this study cannot tell us
Narrative format. Absolute risk increase is modest. Difficult to separate drug effect from rapid weight loss effect. Prevention strategies not well established.
Read the original research
GLP-1 receptor agonists and gallbladder disease risk: insights into molecular mechanisms and clinical implications.
Therapeutic advances in endocrinology and metabolism, 16, 20420188251406456
Citation
Ramírez-Mejía, Mariana M; Ponciano-Rodriguez, Guadalupe; Eslam, Mohammed; Méndez-Sánchez, Nahum. (2025). GLP-1 receptor agonists and gallbladder disease risk: insights into molecular mechanisms and clinical implications.. Therapeutic advances in endocrinology and metabolism, 16, 20420188251406456. https://doi.org/10.1177/20420188251406456